Allergologia et immunopathologiaHumansFemaleAminopyridinesBreast NeoplasmsBenzimidazoles
First successful desensitization with Abemaciclib in an adult patient with breast cancer: A case report.
Merve Hörmet İğde, Şule Çelik Kamacı, Pelin Korkmaz, İlkim Deniz Toprak, Özdemir Can Tüzer, Osman Ozan Yeğit, Derya Ünal, Semra Demir, Aslı Gelincik
Published: 202510.15586/aei.v53i6.1396
Abstract
Abemaciclib, a cyclin-dependent kinase 4/6 (CDK4/6) inhibitor, is an effective targeted therapy for hormone receptor-positive (HR+), HER2-negative, advanced or metastatic breast cancer. While nonimmediate hypersensitivity reactions (NIHRs) have been…
Preview only. Read the full abstract at the source